Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Research article

Peripheral artery disease in peritoneal dialysis and hemodialysis patients: single-center retrospective study in Taiwan

Authors: Chun-Chuan Lee, Chih-Jen Wu, Li-Hua Chou, Su-Mei Shen, Sheng-Fang Chiang, Pi-Chu Jen, Mei-Ching Yeh, Chi-Feng Pan

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

Peripheral artery disease (PAD) is a condition characterized by restricted blood flow to the extremities, and is especially common in the elderly. PAD increases the risk for mortality and morbidity in patients with end-stage renal disease (ESRD), especially those on hemodialysis (HD).

Methods

The records of 484 patients with end-stage renal disease who were on HD or peritoneal dialysis (PD) were reviewed. PAD was diagnosed based on the ankle-brachial pressure index (ABI). Demographic and clinical characteristics were analyzed.

Results

PAD had an overall prevalence of 18.2% and was significantly more common in HD patients (21.8%) than in PD patients (4.8%). Advanced age, diabetes mellitus, smoking, low parathyroid hormone level, elevated serum ferritin, elevated serum glucose, and low serum creatinine levels increased the risk for PAD. PAD was independently associated with advanced age, diabetes mellitus, duration of dialysis, low serum creatinine, and hyperlipidemia. PD patients had a significantly lower prevalence of PAD than HD patients, maybe due to their younger age and lower prevalence of diabetes mellitus in this present study.

Conclusions

The prevalence of PAD was greater in the HD group than the PD group. Most of the risk factors for PAD were specific to HD, and no analyzed factor was significantly associated with PAD in PD patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998, 32 (Suppl 3): S112-S119.CrossRefPubMed Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998, 32 (Suppl 3): S112-S119.CrossRefPubMed
2.
go back to reference O’Hare A, Johansen KJ: Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol. 2001, 12: 2838-2847.PubMed O’Hare A, Johansen KJ: Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol. 2001, 12: 2838-2847.PubMed
3.
go back to reference Selvin E, Erlinger P: Prevalence of and risk factors for peripheral arterial disease in the United States. results from the national health and nutrition examination survey 1999–2000. Circulation. 2004, 110: 738-743. 10.1161/01.CIR.0000137913.26087.F0.CrossRefPubMed Selvin E, Erlinger P: Prevalence of and risk factors for peripheral arterial disease in the United States. results from the national health and nutrition examination survey 1999–2000. Circulation. 2004, 110: 738-743. 10.1161/01.CIR.0000137913.26087.F0.CrossRefPubMed
4.
go back to reference Hirsch AT, Criqui MH, Treat-Jacobson D, et al: Peripheral arterial disease detection, awareness and treatment in primary care. JAMA. 2001, 286: 1317-1324. 10.1001/jama.286.11.1317.CrossRefPubMed Hirsch AT, Criqui MH, Treat-Jacobson D, et al: Peripheral arterial disease detection, awareness and treatment in primary care. JAMA. 2001, 286: 1317-1324. 10.1001/jama.286.11.1317.CrossRefPubMed
5.
go back to reference Rajagopalan S, Dellegrottaglie S, Furniss AL, et al: Peripheral arterial disease in patients with end-stage renal disease-observations from the dialysis outcomes and practice patterns study (DOPPS). Circulation. 2006, 114: 1914-1922. 10.1161/CIRCULATIONAHA.105.607390.CrossRefPubMed Rajagopalan S, Dellegrottaglie S, Furniss AL, et al: Peripheral arterial disease in patients with end-stage renal disease-observations from the dialysis outcomes and practice patterns study (DOPPS). Circulation. 2006, 114: 1914-1922. 10.1161/CIRCULATIONAHA.105.607390.CrossRefPubMed
6.
go back to reference Criqui MH, Langer RD, Fronek A: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992, 326: 381-386. 10.1056/NEJM199202063260605.CrossRefPubMed Criqui MH, Langer RD, Fronek A: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992, 326: 381-386. 10.1056/NEJM199202063260605.CrossRefPubMed
7.
go back to reference Bartholomew JR, Olin JW: Pathophysiology of peripheral arterial disease and risk factors for its development. Cleve Clin J Med. 2006, 73 (suppl 4): S8-S14.CrossRefPubMed Bartholomew JR, Olin JW: Pathophysiology of peripheral arterial disease and risk factors for its development. Cleve Clin J Med. 2006, 73 (suppl 4): S8-S14.CrossRefPubMed
8.
go back to reference O’Hare AM, Glidden DV, Fox CS, Hsu C: High revalence of peripheral arterial disease in persons with renal insufficiency: Results from the national health and nutrition examination survey 1999–2000. Circulation. 2004, 109: 320-323. 10.1161/01.CIR.0000114519.75433.DD.CrossRefPubMed O’Hare AM, Glidden DV, Fox CS, Hsu C: High revalence of peripheral arterial disease in persons with renal insufficiency: Results from the national health and nutrition examination survey 1999–2000. Circulation. 2004, 109: 320-323. 10.1161/01.CIR.0000114519.75433.DD.CrossRefPubMed
9.
go back to reference Tian S-L, Murphy M, Han Q-F, Lu X-H, Wang T: Prevalence and risk factors for peripheral artery disease among patients on maintenance peritoneal dialysis. Blood Purif. 2010, 30: 50-55. 10.1159/000317121.CrossRefPubMed Tian S-L, Murphy M, Han Q-F, Lu X-H, Wang T: Prevalence and risk factors for peripheral artery disease among patients on maintenance peritoneal dialysis. Blood Purif. 2010, 30: 50-55. 10.1159/000317121.CrossRefPubMed
10.
go back to reference Paraskevas KI, Kotsikoris I, Koupidid SA, Giannoukas AD, Mikhailidis DP: Ankle-brachial index: A marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events. Angiology. 2010, 61: 521-523. 10.1177/0003319710371620.CrossRefPubMed Paraskevas KI, Kotsikoris I, Koupidid SA, Giannoukas AD, Mikhailidis DP: Ankle-brachial index: A marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events. Angiology. 2010, 61: 521-523. 10.1177/0003319710371620.CrossRefPubMed
11.
go back to reference Liu JH, Lin HH, Yang YF, et al: Subclinical peripheral artery disease in patients undergoing peritoneal dialysis: risk factors and outcome. Perit Dial Int. 2009, 29: 64-71.PubMed Liu JH, Lin HH, Yang YF, et al: Subclinical peripheral artery disease in patients undergoing peritoneal dialysis: risk factors and outcome. Perit Dial Int. 2009, 29: 64-71.PubMed
12.
go back to reference Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH: Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA. 1993, 270: 487-489. 10.1001/jama.1993.03510040091035.CrossRefPubMed Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH: Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA. 1993, 270: 487-489. 10.1001/jama.1993.03510040091035.CrossRefPubMed
13.
go back to reference Suominen V, Rantanen T, Venermo M, Saarinen J, Salenius J: Prevalence and risk factors for PAD among patients with elevated ABI. Eur J Vasc Endovasc Surg. 2008, 35: 709-714. 10.1016/j.ejvs.2008.01.013.CrossRefPubMed Suominen V, Rantanen T, Venermo M, Saarinen J, Salenius J: Prevalence and risk factors for PAD among patients with elevated ABI. Eur J Vasc Endovasc Surg. 2008, 35: 709-714. 10.1016/j.ejvs.2008.01.013.CrossRefPubMed
14.
go back to reference O’Hare AM, Hus C-Y, Baccehetti P, Johansen KL: Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol. 2002, 13: 497-503.PubMed O’Hare AM, Hus C-Y, Baccehetti P, Johansen KL: Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol. 2002, 13: 497-503.PubMed
15.
go back to reference Ouriel K, McDonnell AE, Metz CE, Zarins CK: Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery. 1982, 91: 686-693.PubMed Ouriel K, McDonnell AE, Metz CE, Zarins CK: Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery. 1982, 91: 686-693.PubMed
16.
go back to reference Yao ST, Hobbs JT, Irvine WT: Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg. 1969, 56: 676-679. 10.1002/bjs.1800560910.CrossRefPubMed Yao ST, Hobbs JT, Irvine WT: Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg. 1969, 56: 676-679. 10.1002/bjs.1800560910.CrossRefPubMed
17.
go back to reference Feringa HHH, Karagiannis SE, Schouten O, et al: Prognostic significance of decline ankle-brachial index values in patients with suspected or known peripheral arterial disease. Eur J Vasc Surg. 2007, 34: 206-213. 10.1016/j.ejvs.2007.02.018.CrossRef Feringa HHH, Karagiannis SE, Schouten O, et al: Prognostic significance of decline ankle-brachial index values in patients with suspected or known peripheral arterial disease. Eur J Vasc Surg. 2007, 34: 206-213. 10.1016/j.ejvs.2007.02.018.CrossRef
18.
go back to reference Guerrero A, Montes R, Munoz-Tero J, et al: Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant. 2006, 21: 3525-3531. 10.1093/ndt/gfl470.CrossRefPubMed Guerrero A, Montes R, Munoz-Tero J, et al: Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant. 2006, 21: 3525-3531. 10.1093/ndt/gfl470.CrossRefPubMed
19.
go back to reference Tsunoda K, Shimajiri Y, Morita S, et al: Chronic kidney disease has a more powerful impact on peripheral arterial disease than metabolic syndrome in Japanese type 2 diabetic patients. Metab Syndr Relat Disord. 2009, 7: 323-326. 10.1089/met.2008.0074.CrossRefPubMed Tsunoda K, Shimajiri Y, Morita S, et al: Chronic kidney disease has a more powerful impact on peripheral arterial disease than metabolic syndrome in Japanese type 2 diabetic patients. Metab Syndr Relat Disord. 2009, 7: 323-326. 10.1089/met.2008.0074.CrossRefPubMed
20.
go back to reference Depalma RG, Hayes VW, Chow BK, et al: Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the iron (Fe) and atherosclerosis study (FeAST) trial. J Vasc Surg. 2010, 51: 1498-1503. 10.1016/j.jvs.2009.12.068.CrossRefPubMed Depalma RG, Hayes VW, Chow BK, et al: Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the iron (Fe) and atherosclerosis study (FeAST) trial. J Vasc Surg. 2010, 51: 1498-1503. 10.1016/j.jvs.2009.12.068.CrossRefPubMed
21.
go back to reference Muir RL: Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention. J Vasc Nurs. 2009, 27: 26-30. 10.1016/j.jvn.2009.03.001.CrossRefPubMed Muir RL: Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention. J Vasc Nurs. 2009, 27: 26-30. 10.1016/j.jvn.2009.03.001.CrossRefPubMed
22.
go back to reference Subramaniam T, Nang EE, Lim SC, et al: Distribution of ankle-brachial index and the risk factors of peripheral artery disease in a multi-ethnic Asian population. Vasc Med. 2011, 16: 87-95. 10.1177/1358863X11400781.CrossRefPubMed Subramaniam T, Nang EE, Lim SC, et al: Distribution of ankle-brachial index and the risk factors of peripheral artery disease in a multi-ethnic Asian population. Vasc Med. 2011, 16: 87-95. 10.1177/1358863X11400781.CrossRefPubMed
Metadata
Title
Peripheral artery disease in peritoneal dialysis and hemodialysis patients: single-center retrospective study in Taiwan
Authors
Chun-Chuan Lee
Chih-Jen Wu
Li-Hua Chou
Su-Mei Shen
Sheng-Fang Chiang
Pi-Chu Jen
Mei-Ching Yeh
Chi-Feng Pan
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-100

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.